These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 23575072

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Actinomycin D for methotrexate-failed low-risk gestational trophoblastic neoplasia.
    Lurain JR, Chapman-Davis E, Hoekstra AV, Schink JC.
    J Reprod Med; 2012; 57(7-8):283-7. PubMed ID: 22838241
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: factors associated with resistance to single-agent methotrexate chemotherapy.
    Chapman-Davis E, Hoekstra AV, Rademaker AW, Schink JC, Lurain JR.
    Gynecol Oncol; 2012 Jun; 125(3):572-5. PubMed ID: 22449733
    [Abstract] [Full Text] [Related]

  • 7. Weekly intramuscular methotrexate in the treatment of low-risk gestational trophoblastic neoplasia.
    Mohit M, Sarraf Z, Sheikhi G, Robati M, Vasheghani-Farahani A.
    Arch Gynecol Obstet; 2009 Nov; 280(5):775-80. PubMed ID: 19263063
    [Abstract] [Full Text] [Related]

  • 8. The value of an initial drop in human Chorionic gonadotropin levels in predicting a response to methotrexate in women with low-risk gestational trophoblastic neoplasia.
    Banach P, Zaborowski MP, Izycka N, Romala A, Nowak-Markwitz E.
    Ginekol Pol; 2019 Nov; 90(3):141-147. PubMed ID: 30950003
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Outcome of gestational trophoblastic neoplasia: experience from a tertiary cancer centre in India.
    Gulia S, Bajpai J, Gupta S, Maheshwari A, Deodhar K, Kerkar RA, Seth V, Rekhi B, Menon S.
    Clin Oncol (R Coll Radiol); 2014 Jan; 26(1):39-44. PubMed ID: 24051171
    [Abstract] [Full Text] [Related]

  • 13. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
    Homesley HD.
    J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
    [Abstract] [Full Text] [Related]

  • 14. Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia.
    Lybol C, Sweep FC, Harvey R, Mitchell H, Short D, Thomas CM, Ottevanger PB, Savage PM, Massuger LF, Seckl MJ.
    Gynecol Oncol; 2012 Jun; 125(3):576-9. PubMed ID: 22410329
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Single-dose methotrexate regimen in the treatment of low-risk gestational trophoblastic neoplasia.
    Chan KK, Huang Y, Tam KF, Tse KY, Ngan HY.
    Am J Obstet Gynecol; 2006 Nov; 195(5):1282-6. PubMed ID: 16723109
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia.
    Even C, Pautier P, Duvillard P, Floquet A, Kerbrat P, Troalen F, Rey A, Balleyguier C, Tazi Y, Leary A, Augereau P, Morice P, Droz JP, Fizazi K, Lhommé C.
    Eur J Cancer; 2014 Aug; 50(12):2082-9. PubMed ID: 24910417
    [Abstract] [Full Text] [Related]

  • 20. Weekly methotrexate (50mg/m(2)) without dose escalation as a primary regimen for low-risk gestational trophoblastic neoplasia.
    Kang WD, Choi HS, Kim SM.
    Gynecol Oncol; 2010 Jun; 117(3):477-80. PubMed ID: 20347479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.